Newswire (Published: Friday, October 5, 2018, 9:52:00 AM CDT, Received: Friday, October 5, 2018, 11:42:45 AM CDT)

Word Count: 485

By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Prostate Cancer have been published. According to news originating from Bologna, Italy, by NewsRx correspondents, research stated, "We aimed to review the current state-of-the-art imaging methods used for primary and secondary staging of prostate cancer, mainly focusing on multiparametric magnetic resonance imaging and positron-emission tomography/computed tomography with new radiotracers. An expert panel of urologists, radiologists and nuclear medicine physicians with wide experience in prostate cancer led a PubMed/MEDLINE search for prospective, retrospective original research, systematic review, meta-analyses and clinical guidelines for local and systemic staging of the primary tumor and recurrence disease after treatment."

Our news journalists obtained a quote from the research from the University of Bologna, "Despite magnetic resonance imaging having low sensitivity for microscopic extracapsular extension, it is now a mainstay of prostate cancer diagnosis and local staging, and is becoming a crucial tool in treatment planning. Cross-sectional imaging for nodal staging, such as computed tomography and magnetic resonance imaging, is clinically useless even in high-risk patients, but is still suggested by current clinical guidelines. Positron-emission tomography/computed tomography with newer tracers has some advantage over conventional images, but is not cost-effective. Bone scan and computed tomography are often useless in early biochemical relapse, when salvage treatments are potentially curative. New imaging modalities, such as prostate-specific membrane antigen positron-emission tomography/computed tomography and whole-body magnetic resonance imaging, are showing promising results for early local and systemic detection."

According to the news editors, the research concluded: "Newer imaging techniques, such as multiparametric magnetic resonance imaging, whole-body magnetic resonance imaging and positron-emission tomography/computed tomography with prostate-specific membrane antigen, have the potential to fill the historical limitations of conventional imaging methods in some clinical situations of primary and secondary staging of prostate cancer."

For more information on this research see: State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer. International Journal of Urology, 2018;():. (Wiley-Blackwell -; International Journal of Urology -

The news correspondents report that additional information may be obtained from R. Schiavina, Dept. of Urology, University of Bologna, St Orsola-Malpighi Hospital, Bologna, Italy. Additional authors for this research include F. Chessa, M. Borghesi, C. Gaudiano, L. Bianchi, B. Corcioni, P. Castellucci, F. Ceci, I. Ceravolo, G. Barchetti, M. Del Monte, R. Campa, C. Catalano, V. Panebianco, C. Nanni, S. Fanti, A. Minervini and Porrec (see also Oncology - Prostate Cancer).

The direct object identifier (DOI) for that additional information is: This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)


      Imaging Agents


Southern Europe


Science and Technology
      Scientific Research
            Imaging Technology
Entertainment and the Arts
Health and Wellness
      Medical Conditions and Diseases
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
            Urological Diseases
      Medical Specialties and Practices